Log inStart free trialBook a demo
Book a demoLog inStart free trial
Media Database
>
Allison DeAngelis

Allison DeAngelis

Senior Healthcare Reporter at Business Insider

Contact this person
Email address
a*****@*******.comGet email address
Influence score
64
Location
United States
Languages
  • English
Covering topics
  • Biotechnology
  • Health & Medicine

View more media outlets and journalists by signing up to Prowly

View latest data and reach out all from one place
Sign up for free

Recent Articles

businessinsider.com

We just got good news about Pfizer’s COVID-19 vaccine

These are Insider’s biggest healthcare stories for the week ending April 2.
over 3 years ago
bizjournals.com

Rowan Walrath joins Business Journal, covering life sciences - Bost...

Rowan Walrath joins Business Journal, covering life sciences - Boston Business Journal  Boston Business Journal
almost 4 years ago
bizjournals.com

Second-mover advantage: Beyond Moderna, Boston-area firms like Cure...

Second-mover advantage: Beyond Moderna, Boston-area firms like CureVac, Translate Bio, Greenlight and Mass. Eye and Ear are still developing Covid vaccines - Boston Business Journal  Boston Business Journal
almost 4 years ago
bizjournals.com

Medtech VC BioVentures raising $350M fund - Boston Business Journal...

Medtech VC BioVentures raising $350M fund - Boston Business Journal  Boston Business Journal
almost 4 years ago
bizjournals.com

Biogen, messenger RNA and CRISPR creators: These were the top five ...

Biogen, messenger RNA and CRISPR creators: These were the top five stories in Boston biotech - Boston Business Journal  Boston Business Journal
almost 4 years ago
bizjournals.com

After supporting Beth Israel, Aldatu Biosciences launching Covid di...

After supporting Beth Israel, Aldatu Biosciences launching Covid diagnostic testing business - Boston Business Journal  Boston Business Journal
almost 4 years ago
bizjournals.com

Celtics' Wyc Grousbeck, partners launch SPAC - Boston Business Jour...

Celtics' Wyc Grousbeck, partners launch SPAC - Boston Business Journal  Boston Business Journal
almost 4 years ago
bizjournals.com

Omega Funds plans life sciences SPAC - Boston Business Journal - Bo...

Omega Funds plans life sciences SPAC - Boston Business Journal  Boston Business Journal
almost 4 years ago
politico.com

DELEO’S domino effect – VELIS opens up about ALCOHOLISM – BROOKLINE...

DELEO'S domino effect – VELIS opens up about ALCOHOLISM – BROOKLINE rocked by SCHOOL REOPENING  Politico
about 4 years ago
bizjournals.com

Biotech Agios sells cancer portfolio for $2 billion to Serveir - Bo...

Biotech Agios sells cancer portfolio for $2 billion to Serveir - Boston Business Journal  Boston Business Journal
about 4 years ago
bizjournals.com

Top former Alnylam exec Barry Greene named CEO of Sage Therapeutics...

Top former Alnylam exec Barry Greene named CEO of Sage Therapeutics - Boston Business Journal  Boston Business Journal
about 4 years ago
bizjournals.com

Three takeaways from the FDA's initial review of Moderna's Covid-19...

Three takeaways from the FDA's initial review of Moderna's Covid-19 vaccine - Boston Business Journal  Boston Business Journal
about 4 years ago
bizjournals.com

How SPAC mergers became popular in 2020 - Boston Business Journal -...

How SPAC mergers became popular in 2020 - Boston Business Journal  Boston Business Journal
about 4 years ago
bizjournals.com

Head of Mass. biotech industry group MassBio to step down - Boston ...

Head of Mass. biotech industry group MassBio to step down - Boston Business Journal  Boston Business Journal
about 4 years ago
bizjournals.com

Biogen, FDA's Alzheimer's disease collaboration draws criticism - B...

Biogen, FDA's Alzheimer's disease collaboration draws criticism - Boston Business Journal  Boston Business Journal
about 4 years ago
bizjournals.com

Women Who Mean Business: Reshma Kewalramani - Boston Business Journ...

Women Who Mean Business: Reshma Kewalramani - Boston Business Journal  Boston Business Journal
about 4 years ago
bizjournals.com

Neurodegeneration biotech Vigil licenses Amgen Alzheimer's drugs - ...

Neurodegeneration biotech Vigil licenses Amgen Alzheimer's drugs - Boston Business Journal  Boston Business Journal
about 4 years ago
bizjournals.com

Biotech Remix plans RNA therapies for cancer, rare diseases - Bosto...

Biotech Remix plans RNA therapies for cancer, rare diseases  Boston Business Journal
about 4 years ago
bizjournals.com

Moderna reaffirms 20M vaccine dose goal for December - Boston Busin...

Moderna reaffirms 20M vaccine dose goal for December - Boston Business Journal  Boston Business Journal
about 4 years ago
bizjournals.com

With profits down, Boston Scientific sells product line for $800M -...

With profits down, Boston Scientific sells product line for $800M - Boston Business Journal  Boston Business Journal
about 4 years ago
bizjournals.com

Vertex buys back $500M in stock, cell therapy startup raises $42M -...

Vertex buys back $500M in stock, cell therapy startup raises $42M - Boston Business Journal  Boston Business Journal
about 4 years ago